Companies / Actuate Therapeutics, Inc.

Actuate Therapeutics, Inc.

Nasdaq: ACTUCIK 1652935FORT WORTH, TX

Financials

Revenue—
Net income$-22.23M
Total debt—
Cash$8.13M
Diluted EPS$-1.06
Shares outstanding23.9M

Ownership

23.9M shares outstanding · as of May 13, 2026
4.4%Insiders
Ownership
Insiders4.41%1,054,976
Institutions53.48%12,796,683
Public float42.11%10,074,193

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Thomson Todd SDirector · 10% owner
3.78%904,795
Schmitt Daniel MCEOPresident, CEO and Director · Director
0.63%150,181
Kairos Venture Partners II, L.P.Director · 10% owner
——
Lytle Paul JChief Financial Officer
——
Ronneberg Amy LDirector
——

Institutional holders 48

View all →
HolderValue% of shares
BIOS Capital Management, LP$61.51M42.00%
Voss Value Master Fund, LP$7.96M5.43%
Vanguard Group Inc$3.24M2.21%
Geode Capital Management, LLC$625.6K0.95%
Northern Trust Corp$620.7K0.42%
Texas Capital Bank Wealth Management Services Inc$157.0K0.43%
Charles Schwab Investment Management Inc$145.9K0.10%
BlackRock, Inc.$137.8K0.38%
Rock Creek Group, LP$133.2K0.09%
Wells Fargo & COMPANY/MN$123.3K0.08%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
TrimCommon Stock$-523.3K-342K
-79.16%
90,035
0.38% of shares
low
Q2 2025
as of
Barclays PLC
13F manager
NewCommon Stock$228.1K+37K
37,334
0.16% of shares
low
Q3 2025
as of
Barclays PLC
13F manager
TrimCommon Stock$-190.5K-28K
-76.25%
8,865
0.04% of shares
low
Q1 2026
as of
AQR Capital Management, LLC
13F manager
NewCommon Stock$74.3K+27K
27,109
0.11% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$56.4K+21K
+9.91%
228,331
0.95% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
TrimCommon Stock$-52.7K-34K
-61.18%
21,850
0.09% of shares
low
Q4 2025
as of
Barclays PLC
13F manager
AddCommon Stock$37.2K+6K
+68.60%
14,946
0.06% of shares
low
Q1 2026
as of
Royal Bank of Canada
13F manager
TrimCommon Stock$-35.8K-13K
-36.97%
22,225
0.09% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ACTUCommon StockEquity005083100BBG00NK7LK03